Literature DB >> 15070789

Childhood vaccination and type 1 diabetes.

Anders Hviid1, Michael Stellfeld, Jan Wohlfahrt, Mads Melbye.   

Abstract

BACKGROUND: A link between childhood vaccinations and the development of type 1 diabetes has been proposed.
METHODS: We evaluated a cohort comprising all children born in Denmark from January 1, 1990, through December 31, 2000, for whom detailed information on vaccinations and type 1 diabetes was available. Using Poisson regression models, we estimated rate ratios according to vaccination status, including the trend associated with the number of doses, among all children and in a subgroup of children who had siblings with type 1 diabetes. Given recent claims of clustering of cases of diabetes two to four years after vaccination, we also estimated rate ratios during the period after vaccination.
RESULTS: Type 1 diabetes was diagnosed in 681 children during 4,720,517 person-years of follow-up. The rate ratio for type 1 diabetes among children who received at least one dose of vaccine, as compared with unvaccinated children, was 0.91 (95 percent confidence interval, 0.74 to 1.12) for Haemophilus influenzae type b vaccine; 1.02 (95 percent confidence interval, 0.75 to 1.37) for diphtheria, tetanus, and inactivated poliovirus vaccine; 0.96 (95 percent confidence interval, 0.71 to 1.30) for diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine; 1.06 (95 percent confidence interval, 0.80 to 1.40) for whole-cell pertussis vaccine; 1.14 (95 percent confidence interval, 0.90 to 1.45) for measles, mumps, and rubella vaccine; and 1.08 (95 percent confidence interval, 0.74 to 1.57) for oral poliovirus vaccine. The development of type 1 diabetes in genetically predisposed children (defined as those who had siblings with type 1 diabetes) was not significantly associated with vaccination. Furthermore, there was no evidence of any clustering of cases two to four years after vaccination with any vaccine.
CONCLUSIONS: These results do not support a causal relation between childhood vaccination and type 1 diabetes. Copyright 2004 Massachusetts Medical Society

Entities:  

Mesh:

Year:  2004        PMID: 15070789     DOI: 10.1056/NEJMoa032665

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  26 in total

Review 1.  Virus infections in type 1 diabetes.

Authors:  Ken T Coppieters; Tobias Boettler; Matthias von Herrath
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

2.  What should an ideal vaccine postlicensure safety system be?

Authors:  Marie R Griffin; M Miles Braun; Kenneth J Bart
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

3.  Childhood immunization controversies: what are parents asking?

Authors:  Daniel R Bronfin
Journal:  Ochsner J       Date:  2008

Review 4.  Prevention strategies for type 1 diabetes.

Authors:  Christopher M Kishiyama; H Peter Chase; Jennifer M Barker
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

Review 5.  Protection against or triggering of Type 1 diabetes? Different roles for viral infections.

Authors:  Tobias Boettler; Matthias von Herrath
Journal:  Expert Rev Clin Immunol       Date:  2011-01       Impact factor: 4.473

Review 6.  Pulmonary vascular dysfunction in metabolic syndrome.

Authors:  Conor Willson; Makiko Watanabe; Atsumi Tsuji-Hosokawa; Ayako Makino
Journal:  J Physiol       Date:  2018-09-12       Impact factor: 5.182

Review 7.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

8.  Live attenuated enterovirus vaccine (OPV) is not associated with islet autoimmunity in children with genetic susceptibility to type 1 diabetes: prospective cohort study.

Authors:  Hanna Viskari; Sami Oikarinen; Sanna Hoppu; Tytti Vuorinen; Heini Huhtala; Jorma Toppari; Riitta Veijola; Jorma Ilonen; Mikael Knip; Heikki Hyöty
Journal:  Diabetologia       Date:  2017-09-02       Impact factor: 10.122

Review 9.  Clinical trials of human papillomavirus vaccines and beyond.

Authors:  Matti Lehtinen; Joakim Dillner
Journal:  Nat Rev Clin Oncol       Date:  2013-06-04       Impact factor: 66.675

Review 10.  Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?

Authors:  Maria Vadalà; Dimitri Poddighe; Carmen Laurino; Beniamino Palmieri
Journal:  EPMA J       Date:  2017-07-20       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.